Related Experiment Videos
The carcinogenic potential of cytotoxic chemotherapy and its implications for therapeutic decision-making
Cancer Chemotherapy and Pharmacology
|January 1, 1984
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinical strategy for the development of angiogenesis inhibitors.
The oncologist·2000
Clinical research and drug development of antivirals in HIV: an industry perspective.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995
Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.
NCI monographs : a publication of the National Cancer Institute·1988
Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1987
Calibrated phase II clinical trials in oncology.
Statistics in medicine·1986
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.
Cancer chemotherapy and pharmacology·2026
Population pharmacokinetic analysis of pirtobrutinib, a non-covalent BTK inhibitor, in patients with hematological malignancies from the Phase 1/2 BRUIN study.
Cancer chemotherapy and pharmacology·2026
Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.
Cancer chemotherapy and pharmacology·2026
Crossing the toxicity threshold: a repeated landmark analysis of early toxicities and treatment modification during first-line CDK4/6 inhibitor therapy.
Cancer chemotherapy and pharmacology·2026
CNS distribution and preclinical activity of the PI3K/AKT inhibitors inavolisib and ipatasertib in pediatric-type diffuse high-grade gliomas.
Cancer chemotherapy and pharmacology·2026
Outcomes of locally produced donor-derived anti-CD19 chimeric antigen receptor T-cells in relapsed or refractory B-cell acute lymphoblastic leukemia patients.
Cancer chemotherapy and pharmacology·2026
Unravelling the synergistic potential of Olibanum extract and Bacillus clausii in combating intestinal cryptosporidiosis in immunosuppressed mice.
PLoS neglected tropical diseases·2026